BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25001638)

  • 21. Pharmaceutical Manipulations for Ocular Drug Delivery.
    Tiwary AK
    Recent Pat Drug Deliv Formul; 2019; 13(4):244-245. PubMed ID: 32400325
    [No Abstract]   [Full Text] [Related]  

  • 22. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
    Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
    J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The suprachoroidal pathway: a new drug delivery route to the back of the eye.
    Rai Udo J; Young SA; Thrimawithana TR; Abdelkader H; Alani AW; Pierscionek B; Alany RG
    Drug Discov Today; 2015 Apr; 20(4):491-5. PubMed ID: 25448755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advancements in ocular drug delivery.
    Weiner AL; Gilger BC
    Vet Ophthalmol; 2010 Nov; 13(6):395-406. PubMed ID: 21182726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Posterior drug delivery via periocular route: challenges and opportunities.
    Waite D; Wang Y; Jones D; Stitt A; Raj Singh TR
    Ther Deliv; 2017 Jul; 8(8):685-699. PubMed ID: 28730942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted Drug Delivery Within the Eye Through the Suprachoroidal Space.
    Patel SR; Prausnitz MR
    J Ocul Pharmacol Ther; 2016 Dec; 32(10):640-641. PubMed ID: 27849435
    [No Abstract]   [Full Text] [Related]  

  • 27. Contact lenses: promising devices for ocular drug delivery.
    Guzman-Aranguez A; Colligris B; Pintor J
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):189-99. PubMed ID: 23215541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent perspectives in ocular drug delivery.
    Gaudana R; Jwala J; Boddu SH; Mitra AK
    Pharm Res; 2009 May; 26(5):1197-216. PubMed ID: 18758924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery.
    Bhattacharjee A; Das PJ; Adhikari P; Marbaniang D; Pal P; Ray S; Mazumder B
    Eur J Ophthalmol; 2019 Jan; 29(1):113-126. PubMed ID: 29756507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendrimer nanoparticles for ocular drug delivery.
    Kambhampati SP; Kannan RM
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):151-65. PubMed ID: 23410062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics.
    Grimaudo MA; Pescina S; Padula C; Santi P; Concheiro A; Alvarez-Lorenzo C; Nicoli S
    Expert Opin Drug Deliv; 2019 Apr; 16(4):397-413. PubMed ID: 30889977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular Drug Delivery.
    Yavuz B; Kompella UB
    Handb Exp Pharmacol; 2017; 242():57-93. PubMed ID: 27783270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in ocular drug delivery.
    Rawas-Qalaji M; Williams CA
    Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent patents on ophthalmic nanoformulations and therapeutic implications.
    Ako-Adounvo AM; Nagarwal RC; Oliveira L; Boddu SH; Wang XS; Dey S; Karla PK
    Recent Pat Drug Deliv Formul; 2014; 8(3):193-201. PubMed ID: 25262835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depot formulations to sustain periocular drug delivery to the posterior eye segment.
    Agban Y; Thakur SS; Mugisho OO; Rupenthal ID
    Drug Discov Today; 2019 Aug; 24(8):1458-1469. PubMed ID: 30930148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug delivery to the posterior segment of the eye.
    Fischer N; Narayanan R; Loewenstein A; Kuppermann BD
    Eur J Ophthalmol; 2011; 21 Suppl 6():S20-6. PubMed ID: 23264325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of lipid nanoparticles to ocular drug delivery.
    Battaglia L; Serpe L; Foglietta F; Muntoni E; Gallarate M; Del Pozo Rodriguez A; Solinis MA
    Expert Opin Drug Deliv; 2016 Dec; 13(12):1743-1757. PubMed ID: 27291069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Periocular routes for retinal drug delivery.
    Raghava S; Hammond M; Kompella UB
    Expert Opin Drug Deliv; 2004 Nov; 1(1):99-114. PubMed ID: 16296723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell penetrating peptides in ocular drug delivery: State of the art.
    Pescina S; Ostacolo C; Gomez-Monterrey IM; Sala M; Bertamino A; Sonvico F; Padula C; Santi P; Bianchera A; Nicoli S
    J Control Release; 2018 Aug; 284():84-102. PubMed ID: 29913221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery.
    Qi Q; Wei Y; Zhang X; Guan J; Mao S
    J Control Release; 2023 Sep; 361():191-211. PubMed ID: 37532148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.